Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma

Zejia Yang(University of Maryland, Baltimore), Hancai Dan(University of Maryland, Baltimore)

Cell Death Discovery

May 15, 2020

10.1038/s41420-020-0270-7

Cited by 17

Related Papers

Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks

|Cells|2019|84

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway

|BMC Cancer|2019|41